Form 4: Disc Medicine's Chief Medical Officer Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., sold 1,500 shares of common stock at a price of $50.59 per share on September 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On September 3, 2024, William Jacob Savage, the Chief Medical Officer of Disc Medicine, Inc. (IRON), sold 1,500 shares of the company's common stock.
- The sale was executed at a price of $50.59 per share.
- Following the transaction, Savage directly owns 41,905 shares of Disc Medicine, Inc.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 16, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.
Key Dates
| Date | Description |
|---|---|
| February 16, 2023 | Date of adoption of the Rule 10b5-1 trading plan |
| September 3, 2024 | Date of the stock sale transaction |
| September 5, 2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.